By The Petrie-Flom Center
We’re excited to introduce and welcome Katharine Van Tassel to our blogging community. She is the Editor of the Health Law Prof Blog, as well as a Contributing Editor of the blog Bio Law: Law and the Life Sciences, and will be cross-posting material here.
Katharine is Professor of Law at the University of Akron. She currently serves on the Executive Board of the Law, Medicine and Healthcare Section of the American Association of Law Schools, on the Executive Board of the Law and Mental Disability Section of the American Association of Law Schools and as the Co-Chair of the Food & Drug Law Committee of the Administrative Law Section of the American Bar Association. She is a Hearing Officer for medical staff peer review proceedings and is a consultant for matters involving the abuse and neglect of nursing home residents. She has served as a member of both the Clinical Ethics Review Team and the Institutional Review Board for Experimental Drugs and Devices of the largest hospital system in Western Massachusetts.
Some of Katharine’s representative work includes:
- Product Recalls for Innovative Biotechnologies, 2013 U. Chi. Leg. F. XX (2013)(invited article for symposium Frontiers of Consumer Protection).
- Blacklisted: The Constitutionality of the Federal System for Publishing Reports of ‘Bad Doctors’ in the National Practitioner Data Bank, 33 Cardozo L. Rev. 101-65 (2012).
- The Growing Consumer Exposure to Nanotechnology in Everyday Products: Regulating Innovative Technologies in Light of Lessons from the Past, 44 Conn. L. Rev. 481-530 (2012) (with Professor Rose Goldman of the Harvard School of Public Health).
- Hospital Peer Review Standards and Due Process: Moving From Tort Theories To Contract Principles Based on Clinical Practice Guidelines, 36 Seton Hall L. Rev.1179-1256 (2006).
- The Introduction of Biotech Foods to the Tort System: Creating a New Duty To Identify, 72 U. Cinn. L. Rev. 1645-1705 (2004).
Welcome, Katharine!
